PANews reported on August 12th that 180 Life Sciences ( ETHZilla ) announced it currently holds 82,186 Ethereum ( ETH ) at an average purchase price of $ 3,806.71 , with a total market value of approximately $ 349 million. The company also holds approximately $ 238 million in cash equivalents. ETHZilla plans to hold the newly acquired ETH for the long term and, in partnership with Electric Capital , utilize a proprietary Ethereum network strategy to generate returns through staking. The company is accelerating its transformation into an institutional-grade Ethereum reserve management platform and continues to advance its gaming and biotech businesses.
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.